Adage Capital Management
Adage Capital is a Boston-based hedge fund founded by Phillip Gross which held nearly $24 billion in securities at the end of the quarter ended September 30, 2010.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
View Older Stories View More Recent Stories
-
Form SC 13G SUTRO BIOPHARMA, INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Opti
-
Soleno Therapeutics (SLNO) Prices 3M Share Offering at $20/sh; Concurrent Private Placement
-
Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
-
Form SC 13G CymaBay Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Verastem, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Benitec Biopharma Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
AN2 Therapeutics Announces Pricing of $70.0 Million Underwritten Offering of Common Stock
-
Tudor, Adage Capital among hedge funds making bets on NYC office space
-
Form 13F-NT Adage Capital Management For: Jun 30
-
Form 13F-HR ADAGE CAPITAL PARTNERS For: Jun 30
-
Gracell Biotechnologies Reports Second Quarter 2023 Unaudited Financial Results and Provides Corporate Update
-
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
-
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering
-
Benitec Biopharma (BNTC) Prices 15.54M Share Offering at $1.93/sh
-
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
-
Gracell Biotechnologies (GRCL) Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
-
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
-
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
-
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
-
Form SC 13G/A GCM Grosvenor Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Molecular Templates, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
HawkEye 360 Receives $58 Million in Series D-1 Funding to Introduce a New Satellite Architecture and Accelerate Data Science Efforts
-
Molecular Templates (MTEM) Announces Up to $40 Million Private Placement Offering of Common Stock, Warrants
-
Molecular Templates Announces Up to $40 Million Private Placement Offering
-
Savara (SVRA) Prices 21M Share Offering at $3/sh
-
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Form SC 13G/A ABEONA THERAPEUTICS INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G MARINUS PHARMACEUTICALS, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Abeona Therapeutics (ABEO) Announces $25 Million Registered Direct Offering of Common Stock, Warrants
-
Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Form SC 13G Praxis Precision Medicin Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Disc Medicine, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G REATA PHARMACEUTICALS Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G TScan Therapeutics, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
ImaginAb Advances Two Solid Tumor Radiopharmaceutical Therapy (RPT) Candidates Towards Clinical Development
-
Akero Therapeutics (AKRO) Prices 5.24M Share Offering at $42/sh
-
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
-
X4 Pharmaceuticals (XFOR) Announces $65 Million Private Placement of Common Stock, Warrants
-
X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market
-
Volatile banking sector saw big moves from funds in first quarter
-
Form 13F-HR ADAGE CAPITAL PARTNERS For: Mar 31
-
Ikena Oncology Inc. (IKNA) Announces 6.11M Share Offering at $6.55/sh
-
Ikena Oncology Announces $40 Million Underwritten Offering
-
Ikena Oncology Announces $40 Million Underwritten Offering
-
EIP Pharma to Present at JMP Securities Life Sciences Conference
-
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
-
MeiraGTx Holdings plc (MGTX) Announces 10.7M Share Private Placement at $5.75/sh
-
MeiraGTx Announces $60 Million Private Placement of Ordinary Shares

